Jubilant Organosys

Rediff.com » News » Jubilant Organosys

News for Jubilant Organosys

Business

Expats drive Jubilant's drug discovery business

Increasing band of expats is driving the Jubilant Organosys drug development and discovery business. Of the total 1,025 scientific manpower strength, the company has attracted nearly 70 expatriates......

Jubilant acquires DRAXIS for $225 mn

Leading contract drug maker Jubilant Organosys on Friday announced the acquisition of Canadian speciality drug company DRAXIS Health for $255 million (around Rs 1020 crore). The board of DRAXIS......

Jubilant buys US firm for $138m

Jubilant Organosys Ltd (Jubilant), a leading domestic player in the pharmaceutical custom research and manufacturing services (CRAMS) segment, has acquired 100 per cent stake in US-based contract......

Forex losses dent Biocon, Jubilant net

Foreign exchange losses have impacted the operating results of two more drug majors. Biotech player Biocon and contract manufacturing specialist Jubilant Organosys have posted less profits for the......

Jubilant buys US co for $12.25 mn

Jubilant Organosys on Friday announced the acquisition of US-based Trinity Laboratories Inc along with its wholly-owned subsidiary Trigen Laboratories Inc for $12.25 million. This was announced in......

Jubilant Organosys

News for Jubilant Organosys

Expats drive Jubilant's drug discovery business

Jubilant acquires DRAXIS for $225 mn

Jubilant buys US firm for $138m

Forex losses dent Biocon, Jubilant net

Jubilant buys US co for $12.25 mn

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS